Filter
2370
Text search:
drug
promotion
Featured
Recommendations
201
New Publications
734
Language
Document type
No document type
1511
Studies & Reports
346
Guidelines
253
Strategic & Response Plan
110
Manuals
82
Training Material
27
Situation Updates
14
Fact sheets
14
Infographics
6
Resource Platforms
5
Brochures
2
Countries / Regions
India
127
Kenya
86
Uganda
75
Global
74
South Africa
71
Ethiopia
65
Nigeria
64
Liberia
58
Nepal
54
Western and Central Europe
53
Sierra Leone
51
Ghana
48
Tanzania
45
Malawi
45
Zambia
44
Myanmar / Burma
41
Bangladesh
35
Namibia
34
Latin America and the Carribbean
33
Cambodia
26
Rwanda
26
Philippines
24
Africa
24
Lesotho
22
Zimbabwe
21
Asia
21
Ukraine
18
South–East Asia Region
18
Botswana
17
Eastern Europe
17
Burkina Faso
16
Senegal
16
Congo, Democratic Republic of
16
Indonesia
15
Mozambique
12
Syria
11
Eswatini/ Swaziland
10
Haiti
9
Eastern Europe and Central Asia
8
Thailand
7
Colombia
7
Cameroon
6
Pakistan
6
China
6
Russia
6
Guinea
5
South Sudan
5
Afghanistan
5
East and Southern Africa
5
Laos
5
Germany
4
Brazil
4
Middle East and North Africa
4
Western Pacific Region
4
Albania
4
Georgia
4
Vietnam
4
North America
4
USA
3
Iraq
3
Benin
3
Peru
3
West and Central Africa
3
Moldova
3
Turkey
2
Papua New Guinea
2
Central African Republic
2
North Macedonia
2
Honduras
2
Bolivia
2
Libya
2
Sri Lanka
2
Chile
2
Yemen
2
Paraguay
2
Venezuela
2
Poland
2
Palestine
2
Timor Leste/ East Timor
2
Tajikistan
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Somalia
1
Jordan
1
Lebanon
1
Ireland
1
Sudan
1
Argentina
1
Dominican Republic
1
Switzerland
1
Serbia
1
Hungary
1
El Salvador
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Fiji
1
Bhutan
1
Armenia
1
Mongolia
1
Southern Africa
1
Canada
1
Qatar
1
Bulgaria
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
Turkmenistan
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Belize
1
Costa Rica
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
1103
Public Health
152
Clinical Guidelines
132
Women & Child Health
86
Key Resources
71
Capacity Building
20
Pharmacy & Technologies
12
Toolboxes
HIV
274
Mental Health
245
TB
160
AMR
130
Pharmacy
57
NTDs
57
COVID-19
55
NCDs
51
Caregiver
44
Disability
34
Malaria
34
Refugee
31
Planetary Health
31
Ebola & Marburg
25
Global Health Education
23
Conflict
22
Rapid Response
22
Health Financing Toolbox
15
Cholera
14
2.0 Rapid Response
14
Natural Hazards
7
Polio
5
Zika
4
Specific Hazards
4
Social Ethics
4
Using the WHO model list of essential medicines to update a national essential medicines list
Since 1977, WHO has been working with countries to design the package of essential medicines as an integral component of treatment within the continuum of care, developing and disseminating the Model List
...
In early 2015, the Americas region began to experience a surge in migration flows due in large part to the rise of people emigrating from Venezuela in response to the country’s faltering economy. This swell in migration continued in the years following, as the number of Venezuelans living in Latin
...
The document is a policy brief by the NCD Alliance for the 2023 United Nations High-Level Meeting on Universal Health Coverage (UHC). It highlights the importance of integrating non-communicable diseases (NCDs) into UHC efforts, with the goal of ensuring equitable health access worldwide.
This handbook is an adaptation from the WHO Clinical Handbook Health care for women subjected to intimate partner violence or sexual violence developed by the World Health Organization (WHO), UN Women and United Nations Population Fund. The handbook draws on the work from professionals who are dedic
...
Namibia is no exception to the growingglobal concern on the increasing burden of NCDs. Namibia is an upper middle income country with fast economic growth since independence in 1990. The country is bearing the double burden of communicable and noncommunicable diseases and rapid urbanizat
...
WHO Technical Series 971
Mortality and burden of disease attributable to selected major risks
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines
...
The "Primary Healthcare Standard Treatment Guidelines and Essential Medicines List" by the South African National Department of Health provides evidence-based guidelines for diagnosing and managing common medical conditions at the primary healthcare level. This document includes treatment protocols
...
Draft for consultation
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt
...
